Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Roche Holding Ltd Dividend Right Cert.. We currently have 73 research reports from 6 professional analysts.
Date | Source | Announcement |
---|---|---|
10Dec18 06:03 | GNW | New member proposed for election to Roche Board of Directors |
10Dec18 06:00 | GNW | Changes to the Roche Corporate Executive Committee |
07Dec18 06:00 | GNW | FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer |
05Dec18 13:15 | GNW | Roche's Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment |
05Dec18 06:00 | GNW | FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer |
04Dec18 06:00 | GNW | New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia |
03Dec18 18:30 | GNW | Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors |
Share: